A team led by Reuben Harris, professor in the Department of Biochemistry, Molecular Biology, and Biophysics, and Douglas Yee, director of the Masonic Cancer Center, and professor in the Department of Medicine and Pharmacology, were recently awarded a P01 from NCI.
In the absence of the federal funding, cancer research will be leaning on private funders. But few private funders have the freedom to ask fundamental questions—questions whose answers may not have an immediate clinical impact but can dramatically advance scientific knowledge.
